Acceleron pharma inc (XLRN)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Dec'12
Assets
Current assets:
Cash and cash equivalents

277,486

237,677

169,542

163,609

214,490

144,052

112,427

79,592

69,736

100,150

238,959

30,726

33,157

20,950

31,016

36,995

63,681

27,783

43,438

38,156

39,814

176,460

189,256

204,250

214,135

113,163

116,479

39,611

Collaboration receivables (all amounts are with a related party)

8,435

8,547

6,875

5,447

2,780

7,039

3,258

3,669

3,232

3,570

2,879

2,881

3,570

3,234

3,019

3,239

3,057

3,628

3,950

5,286

4,049

3,367

3,228

3,731

2,633

3,616

4,103

2,776

Prepaid expenses and other current assets

9,284

10,000

10,588

9,508

7,897

7,662

7,093

7,517

5,203

4,446

3,334

3,111

4,086

3,862

3,676

3,081

3,165

2,458

2,536

1,773

2,576

2,480

3,947

2,180

1,685

2,243

2,179

1,474

Short-term investments

136,954

193,692

256,529

267,151

223,106

147,260

195,545

208,338

222,119

177,077

98,266

111,695

108,220

118,740

107,279

83,724

100,784

77,064

72,459

75,798

61,329

0

-

-

-

-

-

-

Total current assets

432,159

449,916

443,534

445,715

448,273

306,013

318,323

299,116

300,290

285,243

343,438

148,413

149,033

146,786

144,990

127,039

170,687

110,933

122,383

121,013

107,768

182,307

196,431

210,161

218,453

119,022

122,761

43,861

Property and equipment, net

6,668

6,812

6,852

6,775

7,027

7,106

6,270

6,868

7,019

6,966

7,211

7,210

7,107

5,201

4,215

4,190

3,724

3,106

2,945

2,902

2,949

3,087

3,379

3,581

3,674

3,705

3,564

4,059

Operating lease - right of use asset, net

22,531

23,908

25,247

26,549

27,817

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

1,597

1,597

1,597

-

1,597

1,132

1,132

1,132

1,132

1,132

1,132

946

946

996

996

796

796

902

902

902

902

902

913

913

913

913

Related party receivables

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

233

Other assets

1,681

1,793

219

76

107

1,702

92

97

105

113

124

91

20

22

6

8

7

368

43

60

69

0

0

0

-

92

22

146

Long-term investments

1,123

22,477

42,218

70,156

75,509

0

11,835

44,328

61,488

95,723

29,372

51,617

71,837

94,692

112,728

141,997

114,188

31,134

32,253

42,641

63,885

0

-

-

-

-

-

-

Total assets

464,162

504,906

519,667

550,868

560,330

314,821

338,117

351,541

370,034

389,177

381,277

208,463

229,129

247,647

262,885

274,230

289,602

146,337

158,420

167,518

175,573

186,296

200,712

214,644

223,040

123,732

127,260

49,212

Liabilities and stockholders’ equity
Current liabilities:
Accounts payable

3,929

2,295

1,854

3,548

3,930

419

1,289

1,269

1,677

1,086

1,024

1,661

911

1,590

2,071

566

1,202

875

2,647

1,790

1,567

724

3,314

2,614

2,295

885

891

642

Accrued expenses

18,189

24,895

23,825

16,762

13,803

18,209

13,144

13,113

11,079

14,936

14,141

11,370

12,968

13,249

12,814

11,824

12,678

12,400

8,968

8,377

6,692

6,848

5,938

6,475

4,659

6,927

5,126

6,153

Deferred revenue

-

-

-

-

-

-

0

0

0

541

541

541

541

541

541

541

541

555

596

666

964

1,162

1,382

1,505

1,735

2,031

2,351

27,840

Accrued litigation settlement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,000

-

-

-

-

Deferred rent

-

-

-

-

-

284

248

190

186

182

178

727

773

769

766

762

758

661

661

605

559

519

478

499

499

499

499

499

Operating lease liability - right of use

6,412

6,183

5,961

5,746

5,537

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Notes payable, net of discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

16,868

7,656

3,668

Total current liabilities

28,530

33,373

31,640

26,056

23,270

18,912

14,681

14,572

12,942

16,745

15,884

14,299

15,193

16,149

16,192

13,693

15,179

14,491

12,872

11,438

9,782

9,253

11,112

16,093

9,188

27,210

16,523

38,802

Operating lease liability - right of use, net of current portion

18,506

20,201

21,852

23,407

24,918

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue, net of current portion

-

-

-

-

-

-

0

0

0

3,161

3,297

3,432

3,567

3,704

3,839

3,973

4,109

4,239

4,374

4,509

4,642

4,816

4,967

5,124

5,241

5,620

6,205

6,760

Deferred rent, net of current portion

-

-

-

-

-

2,381

2,293

2,171

1,992

1,818

1,628

684

760

953

1,146

1,340

1,533

1,157

1,322

1,488

1,653

1,818

1,984

2,088

2,212

2,337

2,463

2,837

Other non-current liabilities

-

-

48

119

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Notes payable, net of current portion and discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10,979

16,525

Warrants to purchase redeemable convertible preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,422

Warrants to purchase common stock

3,304

1,856

1,326

1,389

1,607

1,491

2,031

1,689

1,320

2,236

1,927

1,516

1,289

1,244

12,161

11,368

8,504

17,187

8,064

10,680

13,702

14,124

15,028

21,512

25,942

30,753

16,526

5,229

Total liabilities

50,340

55,430

54,866

50,971

49,795

22,784

19,005

18,432

16,254

23,960

22,736

19,931

20,809

22,050

33,338

30,374

29,325

37,074

26,632

28,115

29,779

30,011

33,091

44,817

42,583

65,920

52,696

71,575

Commitments and contingencies (Note 13)

-

-

-

-

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Stockholders' equity:
Redeemable convertible preferred stock (Note 8)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

268,610

Undesignated preferred stock, $0.001 par value: 25,000,000 shares authorized and no shares issued or outstanding

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Common stock, $0.001 par value: 175,000,000 shares authorized; 53,519,920 and 53,123,567 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

53

53

54

53

53

47

47

47

46

46

45

39

39

39

38

38

38

34

34

34

33

33

33

32

32

29

35

3

Additional paid-in capital

1,176,359

1,160,807

1,152,449

1,142,148

1,135,376

879,099

871,643

858,582

850,597

839,090

803,907

608,493

598,658

590,474

574,834

567,999

562,631

416,926

412,170

407,968

403,960

399,835

393,554

387,790

381,869

250,107

248,750

-

Accumulated deficit

-762,346

-711,407

-687,833

-642,464

-624,602

-586,549

-551,815

-524,477

-495,539

-473,024

-445,097

-419,646

-389,977

-364,491

-345,203

-324,433

-302,417

-307,477

-280,395

-268,537

-258,156

-243,583

-225,966

-217,995

-201,444

-192,324

-174,221

-290,976

Accumulated other comprehensive (loss) income

-244

23

131

160

-292

-560

-763

-1,043

-1,324

-895

-314

-354

-400

-425

-122

252

25

-220

-21

-62

-43

0

-

-

-

-

-

-

Stockholders' Equity Attributable to Parent

413,822

449,476

464,801

499,897

510,535

292,037

319,112

333,109

353,780

365,217

358,541

188,532

208,320

225,597

229,547

243,856

260,277

109,263

131,788

139,403

145,794

156,285

167,621

169,827

180,457

57,812

74,564

-290,973

Total liabilities and stockholders’ equity

464,162

504,906

519,667

550,868

560,330

314,821

338,117

351,541

370,034

389,177

381,277

208,463

229,129

247,647

262,885

274,230

289,602

146,337

158,420

167,518

175,573

186,296

200,712

214,644

223,040

123,732

127,260

49,212